Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland

Diabetes, Metabolic Syndrome and Obesity

Volumn 7, Issue , 2014, Pages 455-465

  Huber, Carola A ^a   Diem, Peter ^b   Schwenkglenks, Matthias ^c   Rapold, Roland ^a   Reich, Oliver ^a  

^a Helsana Group   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chronic diseases; Comorbidity; Costs; Diabetes

Indexed keywords

ADULT; ARTICLE; ASTHMA; BINOMIAL DISTRIBUTION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; ENTEROPATHY; EPILEPSY; FEMALE; GASTRIC HYPERACIDITY; GLAUCOMA; GOUT; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; INSURANCE; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIGRAINE; OSTEOPOROSIS; PAIN; PARKINSON DISEASE; PREVALENCE; PSYCHOSIS; RHEUMATIC DISEASE; SLEEP DISORDER; STATISTICAL MODEL; SWITZERLAND; THYROID DISEASE; TUBERCULOSIS;

EID: 84907876698     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S69520     Document Type: Article

References (44)

1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projec­tion of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes preva­lence. Popul Health Metr. 2010;8(1):29.
2. Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3): 293–301.
3. Luijks H, Schermer T, Bor H, et al. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med. 2012;10(1):128.
4. Adler AI, Stratton IM, Neil HAW, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412–419.
5. Beckman JA, Creager MA, Libby P. Diabetes and atherosclero­sis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–2581.
6. Schmitt-Koopmann I, Schwenkglenks M, Spinas GA, Szucs TD. Direct medical costs of type 2 diabetes and its complications in Switzerland. Eur J Public Health. 2004;14(1):3–9.
7. Simpson SH, Corabian P, Jacobs P, Johnson JA. The cost of major comorbidity in people with diabetes mellitus. CMAJ. 2003;168(13):1661–1667.
8. O’Brien JA, Caro I, Getsios D, Caro JJ. Diabetes in Canada: direct medical costs of major macrovascular complications. Value Health. 2001;4(3):258–265.
9. Pagano E, Bo S, Petrinco M, Rosato R, Merletti F, Gregori D. Factors affecting hospitalization costs in Type 2 diabetic patients. J Diabetes Complications. 2009;23(1):1–6.
10. Pelletier EM, Shim B, Ben-Joseph R, Caro JJ. Economic outcomes associated with microvascular complications of type 2 diabetes mel­litus: results from a US claims data analysis. Pharmacoeconomics. 2009;27(6):479–490.
11. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36(4):1033–1046.
12. Lkhagva D, Kuwabara K, Matsuda S, Gao Y, Babazono A. Assessing the impact of diabetes-related comorbidities and care on the hospital­ization costs for patients with diabetes mellitus in Japan. J Diabetes Complications. 2012;26(2):129–136.
13. Morsanutto A, Berto P, Lopatriello S, et al. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications. 2006;20(3):163–169.
14. Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GA. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006;6(1):84.
15. Bair MJ, Brizendine EJ, Ackermann RT, Shen C, Kroenke K, Marrero DG. Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetes. Diabet Med. 2010;27(5):578–584.
16. Du Y, Heidemann C, Gößwald A, Schmich P, Scheidt-Nave C. Prevalence and comorbidity of diabetes mellitus among non-institu­tionalized older adults in Germany – results of the national telephone health interview survey ‘German Health Update (GEDA)’ 2009. BMC Public Health. 2013;13(1):166.
17. Huber CA, Schwenkglenks M, Rapold R, Reich O. Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011. BMC Endocr Disord. 2014;14(1):44.
18. Herzlinger RE, Parsa-Parsi R. Consumer-driven health care: lessons from Switzerland. JAMA. 2004;292(10):1213–1220.
19. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2011. Oslo: WHO; 2010.
20. Lamers LM, van Vliet RC. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic con­ditions to the Dutch situation. Health Policy. 2004;68(1):113–121.
21. Cossman RE, Cossman JS, James WL, et al. Correlating pharmaceuti­cal data with a national health survey as a proxy for estimating rural population health. Popul Health Metr. 2010;8(1):25.
22. O’Shea M, Teeling M, Bennett K. The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims database. BMC Health Serv Res. 2013;13(1):23.
23. Chini F, Pezzotti P, Orzella L, Borgia P, Guasticchi G. Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sources. BMC Public Health. 2011;11(1): 688.
24. Huber CA, Szucs TD, Rapold R, Reich O. Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health. 2013;13(1):1030.
25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35 (Suppl 1):S64–S71.
26. Schett G, Kleyer A, Perricone C, et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care. 2013;36(2):403–409.
27. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161(16):1989–1996.
28. Mo F, Pogany LM, Li FC, Morrison H. Prevalence of diabetes and cardiovascular comorbidity in the Canadian Community Health Survey 2002–2003. ScientificWorldJournal. 2006;6:96–105.
29. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001;24(9):1614–1619.
30. Lix LM, Quail J, Fadahunsi O, Teare GF. Predictive performance of comorbidity measures in administrative databases for diabetes cohorts. BMC Health Serv Res. 2013;13(1):340.
31. Wang X, Pitchumoni CS, Chandrarana K, Shah N. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol. 2008;14(5):709–712.
32. Krein SL, Heisler M, Piette JD, Makki F, Kerr EA. The effect of chronic pain on diabetes patients’ self-management. Diabetes Care. 2005;28(1):65–70.
33. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464–470.
34. Green LA, Fryer GE Jr, Yawn BP, Lanier D, Dovey SM. The ecology of medical care revisited. N Engl J Med. 2001;344(26):2021–2025.
35. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74(4):511–544.
36. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775–1779.
37. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29(3):725–731.
38. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74(4):511–544.
39. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288(15):1909–1914.
40. Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood). 2009;28(1):75–85.
41. Nutting PA, Dickinson WP, Dickinson LM, et al. Use of chronic care model elements is associated with higher-quality care for diabetes. Ann Fam Med. 2007;5(1):14–20.
42. Vargas RB, Mangione CM, Asch S, et al. Can a chronic care model collaborative reduce heart disease risk in patients with diabetes? J Gen Intern Med. 2007;22(2):215–222.
43. Harris SB, Glazier RH, Tompkins JW, et al. Investigating concor­dance in diabetes diagnosis between primary care charts (electronic medical records) and health administrative data: a retrospective cohort study. BMC Health Serv Res. 2010;10(1):347.
44. Amed S, Vanderloo SE, Metzger D, et al. Validation of diabetes case definitions using administrative claims data. Diabet Med. 2011;28(4):424–427.